NCT06069258

Brief Summary

This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes. The main objectives are: (i) Measure free-living physical activity and sedentary behaviour with an accelerometer device (ii) Examine associations between movement behaviours and anthropometric and diabetes-related biochemical/clinical parameters (iii) Examine associations between movement behaviours and psychological and environmental determinants that influence movement behaviours (iv) Assess the feasibility and acceptability of the physical activity assessment tools as part of routine clinical practice with clinicians and diabetic patients Participants will be invited to wear an accelerometer device for seven days.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
340

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 5, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

April 24, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 26, 2025

Status Verified

February 1, 2025

Enrollment Period

1.7 years

First QC Date

October 1, 2023

Last Update Submit

February 24, 2025

Conditions

Keywords

Physical activityBehaviourmHealth

Outcome Measures

Primary Outcomes (1)

  • Movement behaviour

    Movement behaviour will be assessed using a thigh-worn accelerometer (activPAL, PAL Technologies, Scotland, U.K. www.palt.com). It has no screen to indicate the amount of physical activity being done, so does not act as a motivational device. The activPAL will be used to collect data 24 hours/day over seven consecutive days.

    1 week (duration of the study)

Secondary Outcomes (9)

  • Activity diary

    1 week (duration of the study)

  • Sociodemographic characteristics

    Day 1/baseline

  • Anthropometric parameters

    Day 1/baseline

  • Clinical parameters

    Day 1/baseline

  • Exercise Self-Efficacy

    Day 1/baseline and end of study (day 7)

  • +4 more secondary outcomes

Study Arms (1)

Bahraini adults with type 2 diabetes

Male and female Bahraini adults aged 20-75 years with controlled type 2 diabetes (i.e. HbA1c \<9 on medication).

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Bahraini adults of all ethnicities with controlled diabetes.

You may qualify if:

  • Sex: Men and women are eligible.
  • Age: Individuals aged 20-75 years old are eligible.
  • Ethnicity: Bahraini adults of all ethnic groups are eligible for the study.
  • Type 2 diabetes and glycaemic control: Individuals with controlled type 2 diabetes (i.e. HbA1c \<9 on medication) based on the medical record of each patient's last visit to the health centre for routine follow-up will be eligible if within the last four months. Otherwise, these measurements will be ordered at the first visit to confirm eligibility.
  • Blood pressure: Individuals whose blood pressure is under moderate control will be eligible - specifically, treated or untreated resting systolic/diastolic pressure \< 160/100 mmHg.
  • Lipid control: Individuals with fasting triglyceride concentration \< 600 mg are eligible.

You may not qualify if:

  • HbA1c \>9%
  • Type 1 diabetes
  • Taking insulin
  • Pregnancy
  • Non-ambulant or severely incapacitated with any medical condition(s) reducing ability to stand or mobilize.
  • Currently participating in a study to reduce sedentary behaviour or increase physical activity
  • Language. Inability to read and understand Arabic or English language.
  • Inability to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Isa Town Health Centre

Building 10, Road 43, Manama, Block 743, Bahrain

RECRUITING

Ahmed Ali Kanoo Health Centre

Building 2009, Road 2641, Manama, Block 626, Bahrain

RECRUITING

Halat Bu Maher Health Centre

Building 2858, Road 1653, Muharraq, Block 216, Bahrain

NOT YET RECRUITING

Shaikh Jaber AlSabah Health Centre

Building 6347, Road Nakheel Street, Northern Governorate, Block 518, Bahrain

NOT YET RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor ActivityBehavior

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Ebrahim Rajab, PhD

    Royal College of Surgeons in Ireland - Medical University Bahrain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ebrahim Rajab, PhD

CONTACT

Abeer Alsaweer, MBBS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2023

First Posted

October 5, 2023

Study Start

April 24, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

February 26, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

We plan to make available all de-identified IPD that underlies results in the publication.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data requests can be submitted 6 months after article publication, and the data will be accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
Access Criteria
Data obtained through this study may be provided to qualified researchers with academic interest in diabetes and physical activity. To gain access, requestors will need to sign a data access agreement.

Locations